Diagnostic Yield of Urine Xpert MTB/RIF Ultra in Adults With Suspected Extrapulmonary Tuberculosis.

diagnostic yield extrapulmonary tuberculosis human immunodeficiency virus tuberculosis urine Xpert MTB/RIF Ultra

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 16 04 2024
accepted: 13 06 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: epublish

Résumé

We assessed the diagnostic yield of urine GeneXpert MTB/RIF Ultra and factors associated with a positive test among adult patients suspected to have extrapulmonary tuberculosis. Urine Ultra was positive in 14% of participants with definite or probable tuberculosis. Hospitalization, disseminated tuberculosis, and human immunodeficiency virus infection were associated with a positive result.

Identifiants

DOI: 10.1093/ofid/ofae338 PMID: 38957690 PMC: PMC11218765
pubmed: 38957690
doi: 10.1093/ofid/ofae338
pii: ofae338
pmc: PMC11218765
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofae338

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. All authors: No reported conflicts.

Auteurs

Robert Ndege (R)

Biomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.
Internal Medicine Department, St Francis Regional Referral Hospital, Ifakara, Tanzania.
ORCID: 0000-0002-1253-8970

Martin Rohacek (M)

Biomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.
Internal Medicine Department, St Francis Regional Referral Hospital, Ifakara, Tanzania.

Farida Bani (F)

Biomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Internal Medicine Department, St Francis Regional Referral Hospital, Ifakara, Tanzania.

Omary Ngome (O)

Biomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.

James Okuma (J)

Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Mohamed Sasamalo (M)

Biomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.

Dorcas Mnzava (D)

Biomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.

Klaus Reither (K)

Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Fiona Vanobberghen (F)

Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Jerry Hella (J)

Biomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.

Daniel H Paris (DH)

Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Maja Weisser (M)

Biomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.
Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Basel, Switzerland.

Classifications MeSH